Skip to content

A Phase 1 first-in-human study to evaluate SAR448272 in adult participants

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-526014-87-00
Enrollment
147
Registered
2026-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers, immunological diseases

Interventions

None listed

Sponsors

Sanofi-Aventis Recherche & Developpement
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Jun 20, 2026